CORMEDIX INC. FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

Edgar Glimpses |

Item 5.07. Submission of Matters to a Vote of Security Holders.

The Company's 2014 annual meeting of stockholders was held on June 25, 2014. At the meeting, stockholders elected the following seven members to the Company's Board of Directors for a term expiring at the annual meeting of stockholders in 2015, based on the following votes:

Member For Withheld Broker Non-Votes Matthew Duffy 10,831,938 2,966,983 0 Michael W. George 13,060,572 738,349 0 Steven Lefkowitz 13,632,077 166,844 0 Taunia Markvicka 13,796,066 2,855 0 Randy Milby 12,603,272 1,195,649 0 Antony E. Pfaffle, M.D. 13,653,317 145,604 0 Cora M. Tellez 13,060,572 738,349 0

At the meeting, stockholders also ratified the appointment of Friedman LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014. The vote for such ratification was 13,765,181 shares for, 31,740 shares against, 2,000 shares abstaining and no broker non-votes.

Item 8.01. Other Events.

On June 23, 2014, CorMedix issued a press release announcing that the protocol for a planned pivotal Phase 3 study for Neutrolin® for use in hemodialysis patients with a central venous catheter has been finalized.

A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits Exhibit No. Description 99.1 Press release dated June 23, 2014 2


DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
URHG United Res Hldgs Grp Inc 0.02 0.00 0.00 0


Emerging Growth

Cavitation Techs Inc

Cavitation Technologies Inc engineers and designs Nano technology based systems that have potential applications in industrial liquid processing.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.